Movicol Junior Neutral Mixtúruduft, lausn 6,9 g איסלנד - איסלנדית - LYFJASTOFNUN (Icelandic Medicines Agency)

movicol junior neutral mixtúruduft, lausn 6,9 g

norgine healthcare b.v. - macrogol 3350; sodium hydrogen carbonate; kalii chloridum; sodium chloride - mixtúruduft, lausn - 6,9 g

Biphozyl (Calfodil) Blóðskilunar-/blóðsíunarlausn 22 mmól/l איסלנד - איסלנדית - LYFJASTOFNUN (Icelandic Medicines Agency)

biphozyl (calfodil) blóðskilunar-/blóðsíunarlausn 22 mmól/l

baxter holding b.v.* - magnesii chloridum; natrii chloridum; sodium hydrogen carbonate; kalii chloridum; dinatrii hydrogenophosphas - blóðskilunar-/blóðsíunarlausn - 22 mmól/l

Gaviscon Tuggutafla איסלנד - איסלנדית - LYFJASTOFNUN (Icelandic Medicines Agency)

gaviscon tuggutafla

nordic drugs ab - aluminium hydroxide; sodium hydrogen carbonate; acidum alginicum - tuggutafla

Movicol Mixtúruduft, lausn 13,8 g איסלנד - איסלנדית - LYFJASTOFNUN (Icelandic Medicines Agency)

movicol mixtúruduft, lausn 13,8 g

norgine healthcare b.v. - macrogol 3350; sodium chloride; sodium hydrogen carbonate; kalii chloridum - mixtúruduft, lausn - 13,8 g

Phoxilium Blóðskilunar-/blóðsíunarlausn 1,2 mmol/l איסלנד - איסלנדית - LYFJASTOFNUN (Icelandic Medicines Agency)

phoxilium blóðskilunar-/blóðsíunarlausn 1,2 mmol/l

baxter holding b.v.* - calcium chloride; magnesii chloridum; sodium chloride; sodium hydrogen carbonate; kalii chloridum; disodium phosphate dodecahydrate - blóðskilunar-/blóðsíunarlausn - 1,2 mmol/l

Wakix האיחוד האירופי - איסלנדית - EMA (European Medicines Agency)

wakix

bioprojet pharma - pitolisant - narcolepsy - Önnur lyf í taugakerfinu - wakix is indicated in adults, adolescents and children from the age of 6 years for the treatment of narcolepsy with or without cataplexy (see also section 5.

Ozawade האיחוד האירופי - איסלנדית - EMA (European Medicines Agency)

ozawade

bioprojet pharma - pitolisant - sleep apnea, obstructive - Önnur lyf í taugakerfinu - ozawade is indicated to improve wakefulness and reduce excessive daytime sleepiness (eds) in adult patients with obstructive sleep apnoea (osa).